ROME — Candesartan helped prevent the development of new retinopathy in patients with type 1 diabetes, and prevented worsening eye disease in patients with type 1 and type 2 diabetes, data from an international study program showed. This was true even though the primary end points of the individual studies were not met.
PREVIEW